Attached files
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 25, 2015
GREENHOUSE SOLUTIONS INC.
(Exact name of Registrant as specified in its charter)
Nevada 000-54759 45-2094634
---------------------------- --------------------------- --------------------
(State or other jurisdiction (Commission File Number) (IRS Employer Ident
of incorporation) -ification Number)
8400 East Crescent Pwky.
Suite 600
Greenwood Village, CO 80111
---------------------------------
(Address of principal executive offices)
(970) 439-1905
--------------------------------
(Registrant's Telephone Number, Including Area Code)
---------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
SECTION 7 - REGULATION FD
Item 7.01 Regulation FD
PRESS RELEASE
On April 25, 2015, the Company issued a press release regarding the
addition of Kevin Kjernisted, M.D. to the company's advisory board. A copy of
the press release is attached as Exhibit 99.
SECTION 8 - OTHER EVENTS
Item 8.01 Other Events
On April 25, 2015, the Company announced the addition of Kevin Kjernisted,
M.D. to the Company's advisory board.
Dr. Kevin Kjernisted received his Medical Degree from the University of
Manitoba in 1983. He worked as a general practitioner for 5 years before
completing training to be a psychiatrist at the University of Manitoba. For more
than a decade Dr. Kjernisted was Medical Director of the Anxiety Disorders
Clinic and Director of Research at St. Boniface General Hospital in the
Department of Psychiatry, University of Manitoba before relocating to Vancouver,
Canada where he is currently a Clinical Associate Professor of Psychiatry in the
Faculty of Medicine at the University of British Columbia. Dr. Kjernisted has
acted as principal investigator in over 35 clinical trials investigating
compounds for mood disorders, anxiety disorders, schizophrenia, ADHD and weight
management. His research interests also include the "mind-body connection" which
involves interactions between the brain, the gut and the immune system
(psychoneuroimmunology). Dr. Kjernisted has lectured extensively on this topic
to peers at national and international meetings. Optimal treatment in his busy
clinical practice involves complementary and alternative treatments including
probiotics, exercise and nutraceuticals, along with medications and
psychotherapy, in order to address excessive inflammation and oxidation which
contribute to psychiatric illness, chronic pain, heart disease, liver disease,
diabetes, inflammatory bowel disease, cancer and dementia.
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. The following is a complete list of exhibits filed as part of this
Report.
Exhibit No. Description
99 Press Release issued April 25, 2015
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
GREENHOUSE SOLUTIONS, INC.
Date: April 29, 2015
By: /s/ John Michak, III
-----------------------------------
John Michak, III, COO
